P53 Gene Therapy Sensitizes Resistant Breast Cancer Cells to Doxorubicin Chemotherapy

Publisher: Bentham Science Publishers

E-ISSN: 2210-304x|3|3|165-174

ISSN: 2210-3031

Source: Drug Delivery Letters, Vol.3, Iss.3, 2013-12, pp. : 165-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract